A study published in Lancet Neurology reported that PD patients carrying LRRK2 mutations exhibit significantly increased cholinesterase activity in the cortex, limbic system, and thalamus compared to sporadic PD cases [51]. The gene discussed is BCHE; the disease is Parkinson disease.